SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) earnings per share and revenue

0RG8 earnings per share for the last quarter are 0.86 EUR whereas the estimation was 0.90 EUR which accounts for -4.43% surprise. Företagets omsättning för samma period uppgår till 666.90 M EUR trots den uppskattade siffran 718.95 M EUR. Estimated earnings per share for the next quarter are 1.06 EUR, and revenue is expected to reach 706.12 M EUR. Also watch annual changes over time to get a bigger picture of 0RG8 earnings per share and revenue dynamics.